Skip to main content

Images and Stories for you

This is an operative photograph from the pancreas surgery collection of Dr. Ilango Sethu, one of our senior consultants in pancreatic oncology and oncosurgery.
The patient is a 60 year old gentleman with cancer in the head of the pancreas. He was diagnosed to have pancreatic cancer during the evaluation of jaundice. The patient had a high risk of heart attack and could not be treated by angioplasty. So he underwent coronary bypass surgery after stenting (small net like structure seen on the right of the yellow colored loop). After recovering from the coronary bypass surgery, the patient has undergone a Whipple's operation with resection of the superior mesenteric vein.
The photograph above shows how the vein was separated and removed along with the tumour. This vein was stitched back again and the blood flow to the liver was restored. Such technical advancements can provide good life to patients with pancreatic cancer. Today, we combine such treatments with the state of the art chemotherapy regimens called FOLFIRINOX to prolong life and hope for patients with pancreatic cancer.

 

Image shared from the collection of Dr. Ilango Sethu, Senior Consultant in Pancreatic Oncology and Oncosurgery.
Image shows the presence of a pancreatic fistula following a resection of the pancreas. Patient had undergone a procedure to remove a suspected lesion in the body of the pancreas. The lesion was very close to the pancreatic duct which carries the pancreatic juice to the intestines for digestion. This lady developed leakage of pancreatic juice from the operation. The risk is about 20% in the operation called distal pancreatectomy. To handle this problem, special imaging like the above was performed and the site was marked and glue injection was done initially. Subsequently, we have provided alternative drainage of the pancreatic duct into the stomach. After the corrective drainage, the patient has gained weight and returned to normal life and is back to her hometown.
This was once considered a dreaded complication of pancreatic surgery. Today, we have well established treatment policies in pancreatic units dedicated to the care of these patients. This patient was treated in a government supported insurance program.





Comments

Post a Comment

Popular posts from this blog

Is pancreas cancer curable?

Pancreas cancer is NOT curable at present. It is CONTROLLABLE. The treatment options that make this possible are available in Chennai itself. Better surgery techniques, better medical treatments and better radiation methods have added many years to patients suffering from pancreatic cancer. Pancreatic cancer at the root of the blood vessels - CAN be successfully removed. Pancreas cancer with spread to liver - CAN be removed Every pancreas cancer patient should have hope and persist in improving the outcome by using the option of better surgery, better radiation and better medical treatments.
Post a Comment
Read more

What are the different things that we do in our program that gives us great results?

Many developments have happened in pancreatic cancer surgery in the last decade. For the first time, we are having long term survivors and in Chennai, in our group, we are seeing patients with disease spread to the liver, living for more than one year and in good health. These experiences vindicate our protocol. Today, we discuss how we provide excellent results in Whipple's operation for pancreatic cancer. These techniques are developed for removing the pancreatic cancer with excellent margins. The principle of complete mesopancreas dissection:  If you want best results in Whipple's surgery, the key margin is the retroperitoneal margin, which lies along the margin of the superior mesenteric artery. The longer margin you give, the better the results will be. (The following stuff is highly technical. Please skip it, if it is too much to digest) In 2011, we standardised the artery first approach to pancreatic cancer and since 2016, we use it as a standard process. The next approa...
1 comment
Read more

What is CA 19.9 and why should we test this in pancreas cancer?

CA 19.9 is an essential part of the evaluation of pancreatic cancer. CA stands for Carbohydrate antigen. This CA19.9 is normally produced in two sources in the human body - pancreatic parenchymal cells and the biliary epithelial cells. We still don't know the connection points between the tissue production of CA19.9 and the blood levels. This protein was discovered in the research for large intestinal cancers, but we have found that it is very useful in pancreatic malignancies. A level of > 1000 has a very high chance (around 99%) of pancreatic cancer. The normal level is around 37 U/L and usually the other cutoffs that pancreatic surgeons remember is 100 U/l and 500 u/L, to assess cancer diagnosis and features of advancing disease. It is important to check your CA 19.9 levels after the jaundice is relieved by ERCP and stenting. High levels in the presence of jaundice or cholangitis (infection of the bile ducts) is not useful to assess advanced disease. At PCRRC, we keep 500 u/L...
Post a Comment
Read more